These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2011-001231-23 Estudio fase II para evaluar la eficacia y seguridad de Trastuzumab en combinación con XELOX como primera línea de tratamiento para el cáncer gástrico avanzado o metastásico en pacientes con tumores H... bad-data